ContractTelix Pharmaceuticals LTD • January 25th, 2024 • Pharmaceutical preparations
OFFICE LEASEOffice Lease • January 25th, 2024 • Telix Pharmaceuticals LTD • Pharmaceutical preparations
THIS OFFICE LEASE (this “Lease”) is executed this ____ day of April, 2022 (the “Effective Date”), by and between CREW HQ, LLC, an Indiana limited liability company (“Landlord”), and TELIX PHARMACEUTICALS (US), INC., a Delaware corporation (“Tenant”).
KEY DETAILSTelix Pharmaceuticals LTD • January 25th, 2024 • Pharmaceutical preparations
Employment Agreement by and among Telix Pharmaceuticals and Richard ValeixEmployment Agreement • January 25th, 2024 • Telix Pharmaceuticals LTD • Pharmaceutical preparations
ContractService Agreement • January 25th, 2024 • Telix Pharmaceuticals LTD • Pharmaceutical preparations
LICENSE AGREEMENTLicense Agreement • January 25th, 2024 • Telix Pharmaceuticals LTD • Pharmaceutical preparations
This license agreement (the “Agreement”) is made as of January 16, 2017 (the “Effective Date”) by and between Wilex AG, having its principal place of business at Grillparzerstr. 18, 81675 Munich, Germany (“Wilex”) and Telix International Pty Ltd ACN 616 657 839 having its principal place of business at, at Suite 226, 55 Flemington Road, North Melbourne, Victoria 3051, Australia (“Telix”).
LICENSE AGREEMENTLicense Agreement • January 25th, 2024 • Telix Pharmaceuticals LTD • Pharmaceutical preparations • Indiana
This License Agreement (the “Agreement”), effective as of April 8, 2022 (the “Effective Date”), is entered into by and between Telix International Pty Ltd, an Australian private company with a place of business at Suite 401, 55 Flemington Road, North Melbourne VIC 3051, Australia (“Telix”), Eli Lilly Kinsale Limited, an Irish private limited company with a place of business at Dunderrow, Kinsale Co., Kinsale, Ireland (“Lilly”), and, solely for purposes of Section 10.8, Telix Pharmaceuticals Limited, owner of all of the outstanding stock of Telix and an Australian public company with a place of business at Suite 401, 55 Flemington Road, North Melbourne VIC 3051, Australia (“Telix Parent”). Telix and Lilly may be referred to herein individually as a “Party” or collectively as the “Parties”.
LOAN AGREEMENT OF €4,000,000Loan Agreement • January 25th, 2024 • Telix Pharmaceuticals LTD • Pharmaceutical preparations
The public limited company “IMBC Spinnova”, whose registered office is located at 7000 Mons, rue des Quatre Fils Aymon, 14. Registered in the Hainaut Register of Legal Persons (Mons section) under company number 0870.661.013.
